TippingPoint Biosciences

formerly Tippingpoint Bio

Tipping Point | Innovative Solutions

San Francisco, United States · Founded 2022 · $4.5M raised

Employees
1–10
Founded
2022
Business Model
B2B
Total Funding
$4.5M
Last Round
$4.5M SeedMar 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

TippingPoint Biosciences pioneers new therapies for diseases of chromatin dysfunction by targeting unstructured regions in chromatin proteins and unique inter-molecular interfaces found only in disease-driving chromatin states. The company's platform aims to increase specificity, reduce toxicity, and be less susceptible to drug resistance compared with conventional approaches to drugging chromatin regulatory factors. TippingPoint Biosciences' mission is to treat diseases caused by dysfunctional genome chromatin packaging that are difficult to target using conventional approaches.

Summary

TippingPoint Biosciences is a Biotech company based in San Francisco, United States, founded in 2022. It has raised $4.5M in total across 2 rounds, most recently a $4.5M Seed round in Mar 2026. Investors include SOSV and LKS Fund.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedMar 2026
$4.5M

Sign up to see all 2 events

Funding: Pre-Seed through Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series BTotal funding$650.0MOct 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

TippingPoint Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/tippingpoint-biosciences"><img src="https://indexed.vc/api/badge/company/tippingpoint-biosciences" alt="TippingPoint Biosciences on Indexed.vc" width="260" height="76" /></a>